News - New Sales Force
Chromatics Color Sciences Hires McClinton, Forms Sales and Hospital Staff Training Units
NEW YORK, Jan. 4 /PRNewswire/ -- Chromatics Color Sciences International, Inc. (Nasdaq: CCSI - news) today announced it has formed a five-person sales unit to be led by Dennis McClinton, Vice President, sales. McClinton, has an 18-year background in sales of fetal and neonatal ICU monitoring products at Marquette Medical Systems and will head a staff that averages 10 years experience in that field. The new unit will be responsible for the initial sales activity for the Colormate® TLc-BiliTest™ System -- the Company's device for pain-free, non-invasive monitoring of bilirubin (infant jaundice).
Chromatics also said today that it has hired neonatal nurse clinical specialists to provide training to hospital staffs using the TLc-BiliTest™ System. Additional staff growth is planned in response to the already strong interest in the product from the medical community created through published reports on the device's effectiveness, as well as a series of successful exhibitions and presentations at medical conferences throughout the world during 1998.
While Chromatics remains in ongoing negotiations to reach a definitive agreement with potential global distributors, and continues to move toward the completion of required due diligence, the Company announced in early November it had entered into a manufacturing agreement for the production of the TLc-BiliTest® System, and anticipates initially shipping the newly-manufactured monitors from its own Connecticut office.
The Chromatics sales and hospital staff training units will report to Sheila Kempf, the Vice President of the Company's medical marketing, sales and distribution support division.
Chromatics Chief Executive Officer Darby Macfarlane commented, ''We continue to move forward toward our goal of bringing this important color technology application to the worldwide medical community. The response we have received from physicians so far has been very positive and very gratifying.''
Kempf added, ''I was very pleased that Dennis McClinton decided to join us and will head the sales effort. He's the right person to lead this very knowledgeable and competent group in the sales of this breakthrough product.''
The Colormate® TLc-BiliTest™ has FDA clearance for commercial use and is the fist FDA-cleared non-invasive bilirubin monitoring device for babies of all races, even under phototherapy treatment. A study of the device recently published by Pediatrics, the publication of the American Academy of Pediatrics, found that the TLc-BiliTest™ System was effective in diagnosing and tracking jaundice compared to current invasive techniques involving taking blood from infants -- often repeatedly.
The System is being manufactured under FDA QSR as well as ISO 9000 manufacturing regulatory requirements. The Company's new contract manufacturer is an ISO 9001-certified facility. The System includes a proprietary calibration standard for each infant's non-invasive measurement taken while being measured for hyperbilirubinemia.
Chromatics Color Sciences is in the business of color science.....
Medical applications in addition to the detection and monitoring of bilirubin infant jaundice will require additional clinical trials and FDA clearance.......
Certain of the matters discussed in this announcement contain forward- looking statements.....
SOURCE: Chromatics Color Sciences International, Inc. |
